<DOC>
	<DOCNO>NCT00130195</DOCNO>
	<brief_summary>The purpose study determine clinical efficacy safety imatinib-combined chemotherapy newly diagnose BCR-ABL-positive ALL .</brief_summary>
	<brief_title>Study Imatinib-Combined Chemotherapy BCR-ABL-Positive Acute Lymphoblastic Leukemia ( ALL )</brief_title>
	<detailed_description>Philadelphia chromosome ( Ph ) translocation abnormality lead formation BCR-ABL gene rearrangement . This genetic abnormality occur 30 % adult acute lymphoblastic leukemia ( ALL ) , presence know adverse prognostic factor ALL . Because long-term survival achieve conventional chemotherapy alone , clear medical need alternative treatment approach . Imatinib potent selective inhibitor BCR-ABL protein kinase , report single-agent imatinib induce response substantial proportion Ph-positive ALL ( Ph+ALL ) patient , response durable . The Japan Adult Leukemia Study Group ( JALSG ) therefore start phase 2 study design evaluate clinical effect imatinib-combined chemotherapy newly diagnose BCR-ABL-positive ALL .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Daunorubicin</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Previously untreated BCRABLpositive ALL Age 15 64 year Performance status 0 3 ( ECOG criterion ) Adequate function liver ( serum bilirubin level &lt; 2.0 mg/dL ) , kidney ( serum creatinine level &lt; 2.0 mg/dL ) , heart ( leave ventricular ejection fraction great 50 % severe abnormality detect electrocardiograms echocardiographs ) Written inform consent participate trial Uncontrolled active infection Another severe and/or lifethreatening disease Positive HIV antibody and/or hepatitis B surface ( HBs ) antigen test Another primary malignancy clinically active and/or require medical intervention Pregnant and/or lactate woman Past history renal failure</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>acute lymphoblastic leukemia</keyword>
	<keyword>BCR-ABL</keyword>
	<keyword>Philadelphia-chromosome</keyword>
	<keyword>newly diagnose</keyword>
</DOC>